PTC Therapeutics Inc (PTCT): Next-Year EPS Estimate 235.13%
As of 2026-06-04, PTC Therapeutics Inc (PTCT) has a next-year EPS growth estimate of 235.13%.
On 2026-05-27, analyst consensus for PTCT's next-year EPS growth shifted from 267.08% to 235.13% — a negative change of 31.95 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at -91.70%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 235.13%
- EPS growth this year
- -91.70%
- EPS next quarter (est)
- $0.28
- Last price
- $70.64
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 235.13% | -91.70% | $0.28 | $70.64 |
| 2026-06-03 | 235.13% | -91.70% | $0.28 | $68.68 |
| 2026-06-02 | 235.13% | -91.70% | $0.28 | $68.23 |
| 2026-06-01 | 235.13% | -91.70% | $0.28 | $73.80 |
| 2026-05-31 | 235.13% | -91.70% | $0.28 | $73.85 |
| 2026-05-28 | 235.13% | -91.70% | $0.28 | $71.05 |
| 2026-05-27 | 235.13% | -91.70% | $0.28 | $70.66 |
| 2026-05-26 | 267.08% | -92.75% | $0.27 | $67.65 |
| 2026-05-25 | 267.08% | -92.75% | $0.27 | $68.81 |
| 2026-05-24 | 267.08% | -92.75% | $0.27 | $68.81 |
| 2026-05-21 | 267.08% | -92.75% | $0.27 | $69.79 |
| 2026-05-20 | 267.08% | -92.75% | $0.27 | $71.02 |
| 2026-05-19 | 267.08% | -92.75% | $0.27 | $70.31 |
| 2026-05-18 | 267.08% | -92.75% | $0.27 | $70.15 |
| 2026-05-17 | 267.08% | -92.75% | $0.27 | $71.47 |
| 2026-05-14 | 267.08% | -92.75% | $0.27 | $72.72 |
| 2026-05-13 | 267.08% | -92.75% | $0.27 | $73.64 |
| 2026-05-12 | 267.08% | -92.75% | $0.27 | $75.02 |
| 2026-05-11 | 674.88% | -96.91% | $0.15 | $76.85 |
| 2026-05-10 | 1253.47% | -98.25% | $0.15 | $73.69 |
| 2026-05-07 | 260.53% | -109.40% | -$0.47 | $64.49 |
| 2026-05-06 | 260.53% | -109.40% | -$0.47 | $66.57 |
| 2026-05-05 | 260.53% | -109.40% | -$0.47 | $65.04 |
| 2026-05-04 | 260.53% | -109.40% | -$0.47 | $65.49 |
| 2026-05-03 | 260.51% | -109.70% | -$0.47 | $65.15 |
| 2026-04-30 | 260.51% | -109.70% | -$0.47 | $65.06 |
| 2026-04-29 | 260.51% | -109.70% | -$0.47 | $64.55 |
| 2026-04-28 | 260.52% | -109.75% | -$0.47 | $70.26 |
| 2026-04-27 | 260.52% | -109.75% | -$0.47 | $69.22 |
| 2026-04-26 | 260.52% | -109.75% | -$0.47 | $68.23 |
Recent News
- PTC Therapeutics, Inc. Q1 2026 Earnings Call SummaryMoby
- PTC Therapeutics: Q1 Earnings SnapshotAssociated Press
- PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial ResultsPR Newswire
- PTC Therapeutics to Participate in Upcoming Investor ConferencesPR Newswire
- PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026PR Newswire
- PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026PR Newswire
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR Newswire
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR Newswire
- Netflix initiated, Instacart upgraded: Wall Street's top analyst callsThe Fly
- PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of DirectorsPR Newswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is PTC Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, PTC Therapeutics Inc (PTCT) has a next-year EPS growth estimate of 235.13%, based on analyst consensus.
When was the latest EPS estimate revision for PTCT?▾
The most recent revision occurred on 2026-05-27, when analysts adjusted the next-year EPS growth estimate from 267.08% to 235.13%.
What sector and industry does PTC Therapeutics Inc belong to?▾
PTC Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PTCT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. PTC Therapeutics Inc (PTCT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports